TBX-FREE Sales Surpass 10,000 Units Sold

LOS ANGELES, April 6, 2016 /PRNewswire/ — Redwood Scientific Technologies, Inc. today announced that it has sold over 10,000 units of TBX-FREE since the product first launched in December of 2015.

“We are incredibly proud of the progress TBX-FREE has made in helping smokers around the world quit their harmful addiction to cigarettes,” said Jason Cardiff, President and CEO. “Smokers are clearly responding well to the benefits offered by the oral strip delivery technology that is in TBX-FREE. Simply put: pills, patches, and lozenges are obsolete methods of drug delivery, and given the high number of smokers who fail at quitting; they clearly are ineffective.”

According to the CDC, there are an estimated 40 million smokers within the United States. With such a large amount of potential customers, TBX-FREE is poised to obtain a huge market presence by providing an effective alternative to nicotine replacement therapy. Even more noteworthy is that TBX-FREE has passed the 10,000 units sold mark in the space of only 3 months.

Additionally, customers who complete their first month of TBX-FREE will now receive supplemental material that includes instructions for after their first 30 days, important information on smoking recurrence, a certificate of completion, and other helpful items.

About Redwood Scientific Technologies, Inc.

Redwood Scientific Technologies, Inc. (Redwood), headquartered in Claremont, California, develops and markets FDA registered OTC drugs that can be delivered through the use of thin film technology. Redwood utilizes patent pending sublingual strip delivery technology to enhance the effectiveness and absorption rate in the treatment of medical conditions. The company is aggressively expanding its customer population through national television advertising campaigns while driving consumer awareness and increasing retail expansion.

Back to blog